A detailed history of Al Ti Global, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Al Ti Global, Inc. holds 4,379 shares of NVS stock, worth $576,057. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,379
Previous 4,419 0.91%
Holding current value
$576,057
Previous $535 Million 5.02%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 05, 2025

SELL
$113.5 - $129.73 $4,540 - $5,189
-40 Reduced 0.91%
4,379 $562 Million
Q2 2025

Jul 30, 2025

BUY
$101.96 - $121.01 $450,561 - $534,743
4,419 New
4,419 $535 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $283B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Al Ti Global, Inc. Portfolio

Follow Al Ti Global, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Al Ti Global, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Al Ti Global, Inc. with notifications on news.